vimarsana.com

Page 10 - சபை க்கு மருத்துவ திட்டங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Down a slippery slope: SAHPRA s decision on ivermecti

The recent decision of the SA Health Products Regulatory Authority (SAHPRA) to allow for the dispensing of ivermectin, an anti-parasitic medication authorised for veterinary use, is a study in the law of unintended consequences. These consequences stem from misdirected lobbying for ivermectin’s use in patients with Covid-19 intersecting with the serialised weak governance that we have all become quite accustomed to. The management of SAHPRA largely comprises some of our finest scientific and medicines regulation policy experts, who practice a vital and, for the most part, globally recognised regulatory function. Given its vital role in ensuring the safety and efficacy of medicines in the country, we can all take comfort from its imprimatur on the medicines we consume. That is as it should be and it is to the credit of those in its management, from the board to the executive, that they enjoy the confidence of the country in this task, despite the well-known constraints of inadequat

After R400,000 in bills, a family s medical aid was cancelled – now a court says the scheme must pay

Covid-19 vaccinations: medical schemes ready to pay for their members – The Citizen

Covid-19 vaccinations: medical schemes ready to pay for their members Ina Opperman Private providers will have to be accredited to administer the vaccines. South African medical schemes have finalised their plans to assist their members to get vaccinated against Covid-19, after the Council for Medical Schemes (CMS) released a media statement on 5 January confirming that it is driving public-private sector collaborations to ensure equitable access to the vaccine. Minister of Health Dr Zweli Mkhize identified the vaccine as a prescribed minimum benefit (PMB), which means that the Covid-19 vaccine will be regarded as PMB level of care, and will be funded in full by medical schemes, regardless of the member’s option or available benefits, when it becomes available.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.